Table 4.
AUC | Sensitivity | Specificity | LR | N | |
Whole cohort (AD, MCI, CTL) | 0.742 | 0.682 | 0.704 | 2.30 | 374 |
MCI | 0.743 | 0.658 | 0.785 | 3.06 | 193 |
CTL | 0.768 | 0.682 | 0.776 | 3.04 | 142 |
MCI and CTL combined | 0.724 | 0.677 | 0.661 | 2.00 | 335 |
APOE ɛ4 non-carriers | 0.736 | 0.681 | 0.725 | 2.47 | 199 |
APOE ɛ4 carriers | 0.836 | 0.757 | 0.767 | 3.25 | 175 |
MCI, mild cognitive impairment; AD, Alzheimer’s disease, APOE, apolipoprotein E; CTL, cognitively healthy control; AUC, area under the curve; LR, likelihood ratio.